Invention Grant
- Patent Title: BRK inhibitory compound
-
Application No.: US16472192Application Date: 2017-12-20
-
Publication No.: US11052091B2Publication Date: 2021-07-06
- Inventor: Shingo Yamamoto , Masakuni Kurono , Atsushi Yoshida , Shingo Hotta
- Applicant: ONO PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Osaka
- Assignee: ONO PHARMACEUTICAL CO., LTD.
- Current Assignee: ONO PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Osaka
- Agency: Foley & Lardner LLP
- Priority: JPJP2016-247440 20161221
- International Application: PCT/JP2017/045786 WO 20171220
- International Announcement: WO2018/117177 WO 20180628
- Main IPC: C07D473/14
- IPC: C07D473/14 ; A61K31/52 ; A61P35/00 ; A61K31/5377 ; A61K31/538 ; C07D473/16
Abstract:
The present invention relates to a Brk inhibitory compound represented by general formula (I) (wherein, all symbols represent the same meanings as the symbols set forth in the specification), a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug of any of these.
Public/Granted literature
- US20200000810A1 BRK INHIBITORY COMPOUND Public/Granted day:2020-01-02
Information query
